These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 21345358)

  • 41. Turnover of hepatitis B virus X protein is facilitated by Hdj1, a human Hsp40/DnaJ protein.
    Sohn SY; Kim JH; Baek KW; Ryu WS; Ahn BY
    Biochem Biophys Res Commun; 2006 Sep; 347(3):764-8. PubMed ID: 16842747
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Repression of hepatitis B viral gene expression by transcription factor nuclear factor-kappaB.
    Lin YC; Hsu EC; Ting LP
    Cell Microbiol; 2009 Apr; 11(4):645-60. PubMed ID: 19141126
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Involvement of the Ets-1 gene in overexpression of matrilysin in human hepatocellular carcinoma.
    Ozaki I; Mizuta T; Zhao G; Yotsumoto H; Hara T; Kajihara S; Hisatomi A; Sakai T; Yamamoto K
    Cancer Res; 2000 Nov; 60(22):6519-25. PubMed ID: 11103822
    [TBL] [Abstract][Full Text] [Related]  

  • 44. YY1 transcription factor is not responsible for the negative regulation of hamster Muc1 transcription.
    Hisatsune A; Hyun SW; Lee IJ; Georas S; Kim KC
    Anticancer Res; 2004; 24(1):235-40. PubMed ID: 15015602
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of carcinogen-induced transcription factors on the activation of hepatitis B virus expression in human hepatoblastoma HepG2 cells and its implication on hepatocellular carcinomas.
    Banerjee R; Caruccio L; Zhang YJ; McKercher S; Santella RM
    Hepatology; 2000 Aug; 32(2):367-74. PubMed ID: 10915744
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reduction of double-stranded RNA-activated protein kinase in hepatocellular carcinoma associated with hepatitis B virus.
    Chen GG; Lai PB; Ho RL; Chan PK; Xu H; Wong J; Lau WY
    J Med Virol; 2004 Jun; 73(2):187-94. PubMed ID: 15122791
    [TBL] [Abstract][Full Text] [Related]  

  • 47. HBV preS2 transactivates FOXP3 expression in malignant hepatocytes.
    Zhang X; Gao L; Liang X; Guo M; Wang R; Pan Y; Liu P; Zhang F; Guo C; Zhu F; Qu C; Ma C
    Liver Int; 2015 Mar; 35(3):1087-94. PubMed ID: 25047684
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transactivation of transforming growth factor alpha gene by hepatitis B virus preS1.
    Ono M; Morisawa K; Nie J; Ota K; Taniguchi T; Saibara T; Onishi S
    Cancer Res; 1998 May; 58(9):1813-6. PubMed ID: 9581818
    [TBL] [Abstract][Full Text] [Related]  

  • 49. YY1 promotes HDAC1 expression and decreases sensitivity of hepatocellular carcinoma cells to HDAC inhibitor.
    Dong S; Ma X; Wang Z; Han B; Zou H; Wu Z; Zang Y; Zhuang L
    Oncotarget; 2017 Jun; 8(25):40583-40593. PubMed ID: 28489564
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Yin-Yang 1 and HBx protein activate HBV transcription by mediating the spatial interaction of cccDNA minichromosome with cellular chromosome 19p13.11.
    Shen C; Feng X; Mao T; Yang D; Zou J; Zao X; Deng Q; Chen X; Lu F
    Emerg Microbes Infect; 2020 Dec; 9(1):2455-2464. PubMed ID: 33084547
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Identification of hepatitis B virus integration sites in hepatocellular carcinoma tissues from patients with chronic hepatitis B].
    Tu H; Gao HF; Ma GH; Liu Y
    Zhonghua Yi Xue Za Zhi; 2006 May; 86(18):1249-52. PubMed ID: 16796883
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hepatitis B Virus Pre-S2 Mutant Induces Aerobic Glycolysis through Mammalian Target of Rapamycin Signal Cascade.
    Teng CF; Hsieh WC; Wu HC; Lin YJ; Tsai HW; Huang W; Su IJ
    PLoS One; 2015; 10(4):e0122373. PubMed ID: 25909713
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gluconeogenesis, lipogenesis, and HBV replication are commonly regulated by PGC-1α-dependent pathway.
    Jhuang HJ; Hsu WH; Lin KT; Hsu SL; Wang FS; Chou CK; Lee KH; Tsou AP; Lai JM; Yeh SF; Huang CY
    Oncotarget; 2015 Apr; 6(10):7788-803. PubMed ID: 25762623
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Yin Yang 1 facilitates hepatocellular carcinoma cell lipid metabolism and tumor progression by inhibiting PGC-1β-induced fatty acid oxidation.
    Li Y; Kasim V; Yan X; Li L; Meliala ITS; Huang C; Li Z; Lei K; Song G; Zheng X; Wu S
    Theranostics; 2019; 9(25):7599-7615. PubMed ID: 31695789
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Frequent alteration of the Yin Yang 1/Raf-1 kinase inhibitory protein ratio in hepatocellular carcinoma.
    Notarbartolo M; Giannitrapani L; Vivona N; Poma P; Labbozzetta M; Florena AM; Porcasi R; Muggeo VM; Sandonato L; Cervello M; Montalto G; D'Alessandro N
    OMICS; 2011 May; 15(5):267-72. PubMed ID: 21332389
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hepatitis B virus replication and sex-determining region Y box 4 production are tightly controlled by a novel positive feedback mechanism.
    Shang J; Zheng Y; Guo X; Mo J; Xie X; Xiong Y; Liu Y; Wu K; Wu J
    Sci Rep; 2015 May; 5():10066. PubMed ID: 25970172
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dimethyl sulfoxide promotes the multiple functions of the tumor suppressor HLJ1 through activator protein-1 activation in NSCLC cells.
    Wang CC; Lin SY; Lai YH; Liu YJ; Hsu YL; Chen JJ
    PLoS One; 2012; 7(4):e33772. PubMed ID: 22529897
    [TBL] [Abstract][Full Text] [Related]  

  • 58. HOXD3 was negatively regulated by YY1 recruiting HDAC1 to suppress progression of hepatocellular carcinoma cells via ITGA2 pathway.
    Wang L; Gao Y; Zhao X; Guo C; Wang X; Yang Y; Han C; Zhao L; Qin Y; Liu L; Huang C; Wang W
    Cell Prolif; 2020 Aug; 53(8):e12835. PubMed ID: 32557953
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Yin Yang-1 suppresses differentiation of hepatocellular carcinoma cells through the downregulation of CCAAT/enhancer-binding protein alpha.
    Zhang S; Jiang T; Feng L; Sun J; Lu H; Wang Q; Pan M; Huang D; Wang X; Wang L; Jin H
    J Mol Med (Berl); 2012 Sep; 90(9):1069-77. PubMed ID: 22391813
    [TBL] [Abstract][Full Text] [Related]  

  • 60. HLJ1 is an endogenous Src inhibitor suppressing cancer progression through dual mechanisms.
    Chen CH; Chang WH; Su KY; Ku WH; Chang GC; Hong QS; Hsiao YJ; Chen HC; Chen HY; Wu R; Yang PC; Chen JJ; Yu SL
    Oncogene; 2016 Oct; 35(43):5674-5685. PubMed ID: 27065329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.